Advances in Pathophysiology of Triple-Negative Breast Cancer: The Potential of lncRNAs for Clinical Diagnosis, Treatment, and Prognostic Monitoring

被引:4
|
作者
Zhou, Yangkun [1 ]
Yue, Yang [1 ]
Fan, Siyu [1 ]
Jia, Qiaojun [1 ]
Ding, Xianfeng [1 ]
机构
[1] Zhejiang Sci Tech Univ, Sch Life Sci & Med, Hangzhou 310018, Peoples R China
关键词
Triple-negative breast cancer (TNBC); Long non-coding RNA (lncRNA); Biomarker; Therapeutic target; LONG NONCODING RNA; PROMOTES PROLIFERATION; CELL-PROLIFERATION; INVASION; METASTASIS; APOPTOSIS; PROTEIN; IDENTIFICATION; SUPPRESSES; RESISTANCE;
D O I
10.1007/s12033-021-00368-x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Recent studies have shown that long non-coding RNAs (lncRNAs) are involved in several gene expression regulation processes, including epigenetic regulation, transcriptional regulation, post-transcriptional regulation, and translation regulation. It also plays a crucial role in the regulation of several characteristics of cancer biology, and the dysregulation of lncRNA expression in cancer may be part of the cause of cancer progression. Meanwhile, more and more studies are trying to determine the association between lncRNA expression and TNBC, as well as the functional role and molecular mechanism of the abnormally expressed lncRNA. Therefore, this review lists some abnormal lncRNAs in TNBC, further analyzes their molecular mechanisms and biological roles in the development of TNBC, and summarizes the potential of lncRNAs as biomarkers and therapeutic targets of TNBC, so as to provide ideas for clinical diagnosis, targeted therapy, and prognosis monitoring of TNBC.
引用
收藏
页码:1093 / 1102
页数:10
相关论文
共 50 条
  • [21] The Potential of Hormonal Therapies for Treatment of Triple-Negative Breast Cancer
    Kirkby, Melanie
    Popatia, Alyanna M.
    Lavoie, Jessie R.
    Wang, Lisheng
    CANCERS, 2023, 15 (19)
  • [22] Recent Advances of Nanotechnology in the Diagnosis and Therapy of Triple-Negative Breast Cancer (TNBC)
    Kanugo, Abhishek
    Gautam, Rupesh K.
    Kamal, Mohammad Amjad
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2022, 23 (13) : 1581 - 1595
  • [23] TLR5: A prognostic and monitoring indicator for triple-negative breast cancer
    Shi, Dai
    Zhao, Shanshan
    Jiang, Wen
    Zhang, Chao
    Liang, Ting
    Hou, Guihua
    CELL DEATH & DISEASE, 2019, 10 (12)
  • [24] TLR5: A prognostic and monitoring indicator for triple-negative breast cancer
    Dai Shi
    Shanshan Zhao
    Wen Jiang
    Chao Zhang
    Ting Liang
    Guihua Hou
    Cell Death & Disease, 10
  • [25] Co-expression networks revealed potential core lncRNAs in the triple-negative breast cancer
    Yang, Fan
    Liu, Ye-huan
    Dong, Si-yang
    Yao, Zhi-han
    Lv, Lin
    Ma, Rui-min
    Dai, Xuan-xuan
    Wang, Jiao
    Zhang, Xiao-hua
    Wang, Ou-chen
    GENE, 2016, 591 (02) : 471 - 477
  • [26] Pathological and molecular diagnosis of triple-negative breast cancer: a clinical perspective
    Penault-Llorca, F.
    Viale, G.
    ANNALS OF ONCOLOGY, 2012, 23 : 19 - 22
  • [27] Advances in Targeted Therapies for Triple-Negative Breast Cancer
    McCann, Kelly E.
    Hurvitz, Sara A.
    McAndrew, Nicholas
    DRUGS, 2019, 79 (11) : 1217 - 1230
  • [28] Development of a Prognostic Model Based on the Identification of EMT-Related lncRNAs in Triple-Negative Breast Cancer
    Guo, Jiani
    Yi, Xuesong
    Ji, Zhuqing
    Yao, Mengchu
    Yang, Yu
    Song, Wei
    Huang, Mingde
    JOURNAL OF ONCOLOGY, 2021, 2021
  • [29] Advances in Targeted Therapies for Triple-Negative Breast Cancer
    Kelly E. McCann
    Sara A. Hurvitz
    Nicholas McAndrew
    Drugs, 2019, 79 : 1217 - 1230
  • [30] Advances in the Understanding of the Pathogenesis of Triple-Negative Breast Cancer
    Liu, Yuhan
    Zou, Yuhan
    Ye, Yangli
    Chen, Yong
    CANCER MEDICINE, 2024, 13 (22):